INTERMUNE PHARMACEUTICALS INC
10-Q/A, EX-27, 2000-10-30
PHARMACEUTICAL PREPARATIONS
Previous: INTERMUNE PHARMACEUTICALS INC, 10-Q/A, 2000-10-30
Next: INTERMUNE PHARMACEUTICALS INC, 10-Q/A, 2000-10-30



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
FINANCIAL STATEMENTS FOR THE THREE-MONTH PERIOD ENDING MARCH 31, 2000,
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-2000
<CASH>                                         139,282
<SECURITIES>                                         0
<RECEIVABLES>                                       81
<ALLOWANCES>                                         0
<INVENTORY>                                        281
<CURRENT-ASSETS>                               141,149
<PP&E>                                             424
<DEPRECIATION>                                    (17)
<TOTAL-ASSETS>                                 141,806
<CURRENT-LIABILITIES>                            3,668
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            22
<OTHER-SE>                                     136,449
<TOTAL-LIABILITY-AND-EQUITY>                   141,806
<SALES>                                            106
<TOTAL-REVENUES>                                   106
<CGS>                                               55
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               (6,090)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                (90)
<INCOME-PRETAX>                                (5,632)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (5,632)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (5,632)
<EPS-BASIC>                                    (11.17)
<EPS-DILUTED>                                  (11.17)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission